Inflammatory Breast Cancer Survival: The Role of Obesity and Menopausal Status at Diagnosis Shine ChangJulie R. AlderferAman U. Buzdar OriginalPaper Pages: 157 - 163
Preliminary Assessment of Cognitive Function in Breast Cancer Patients Treated with Tamoxifen Annlia Paganini-HillLinda J. Clark OriginalPaper Pages: 165 - 176
Liarozole Fumarate (R85246): In the Treatment of ER Negative, Tamoxifen Refractory or Chemotherapy Resistant Postmenopausal Metastatic Breast Cancer Paul E. GossKathrin StrasserShangle Qi OriginalPaper Pages: 177 - 188
Polyadenylic–Polyuridylic Acid Plus Locoregional Radiotherapy Versus Chemotherapy with CMF in Operable Breast Cancer: a 14 Year Follow-up Analysis of a Randomized Trial of the Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) A. LaplancheL. AlzieuJ. Lacour OriginalPaper Pages: 189 - 191
Selective Decrease of Serum Immunoglobulin G1 as Marker for Early Stages of Invasive Breast Cancer L. KronbergerW. SteinschifterK. Schauenstein OriginalPaper Pages: 193 - 199
Alcohol and Breast Cancer Mortality in a Cohort Study M.G. JainR.G. FerrenceA.B. Miller OriginalPaper Pages: 201 - 209
Inhibition of NF-κB Activity Enhances TRAIL Mediated Apoptosis in Breast Cancer Cell Lines Maccon M. KeaneYaffa RubinsteinStan Lipkowitz OriginalPaper Pages: 211 - 219
PTP LAR Expression Compared to Prognostic Indices in Metastatic and Non-Metastatic Breast Cancer Charles M. LeVeaCarl T. McGaryRobert A. Mooney OriginalPaper Pages: 221 - 228